FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA – Based on the user fee goal date – April 23, if pixantrone is approved, CTI estimates that pixantrone could be available to patients in the U.S. early in the second quarter of 2010.
FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA – Based on the user fee goal date – April 23, if pixantrone is approved, CTI estimates that pixantrone could be available to patients in the U.S. early in the second quarter of 2010.
ReplyDelete